CD45RC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

56 results for “CD45RC”

Trials

View all 33 →

Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation

150 participants · First posted Jun 21, 2019

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

12 participants · First posted Oct 4, 2021

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

30 participants · First posted Jul 26, 2019

Drugs

View all 20 →

Anti-CD45RC mAb(AbolerIS)

CD45RB mAb

CD45RA depleted leukocytes(University of Pittsburgh)

News

AbolerIS Pharma Initiates First-in-Human Trial of Novel Anti-CD45RC Antibody for Rheumatoid Arthritis

AbolerIS Pharma Advances Novel Anti-CD45RC Antibody ABO21009 to Patient Testing in Rheumatoid Arthritis Phase 1 Trial

Vor Biopharma Announces Positive Data and New CD45 ADC Program, Analysts See Significant Upside

Page 1 of 6